GRAIL Inc.
GRAL
Updated: 25/09/2026, 05:31:54
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
No summaries found.
- Share price
- $125.21
- Market cap
- $5.37B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- Joshua J. Ofman
- Employees
- 910
- IPO date
- 12/06/2024
- Beta
- 3.254
- Last dividend
- $0.00
- Day range
- $101.98 – $126.81
- 52-week range
- $41.50 – $126.81
- 1-day performance
- 15.38%
- 1-year performance
- 201.71%
- Current drawdown (1Y)
- -1.26%
- CIK
- 0001699031
- CUSIP
- 384747101
- ISIN
- US3847471014
- Created
- 07/12/2025, 04:24:28
- Last update
- 25/09/2026, 05:31:54
Track GRAIL Inc. with an AI analyst
See which prediction-market events move GRAL, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
$GRAL Shareholder News: GRAIL Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law about the Ongoing Securities Class Action
GlobeNewsWire • STOCK • 15/06/2026, 08:37:00
GRAL Investors Have Opportunity to Lead GRAIL, Inc. Securities Fraud Lawsuit with the Schall Law Firm
PRNewsWire • STOCK • 15/06/2026, 05:57:00
GRAL INVESTOR DEADLINE: GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Newsfile Corp • STOCK • 14/06/2026, 15:45:00
GRAL UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Grail (GRAL) Investors of Securities Class Action Lawsuit Deadline on August 4, 2026
Newsfile Corp • STOCK • 14/06/2026, 10:20:00
GRAL INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that GRAIL, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewsWire • STOCK • 12/06/2026, 23:00:00
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRAL
Newsfile Corp • STOCK • 12/06/2026, 21:36:00
GRAL Breaking News: GRAIL, Inc. Sued for Securities Fraud after Trial Results Lead to 50% Stock Drop – Investors Notified to Contact BFA Law
Business Wire • STOCK • 12/06/2026, 18:07:00
Bronstein, Gewirtz & Grossman LLC Urges GRAIL, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Newsfile Corp • STOCK • 12/06/2026, 14:00:00
ROSEN, LEADING TRIAL LAWYERS, Encourages GRAIL, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GRAL
Newsfile Corp • STOCK • 11/06/2026, 21:35:00
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines - GRAL
PRNewsWire • STOCK • 11/06/2026, 21:05:00
Securities Fraud Investigation Into Grail, Inc. (GRAL) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Business Wire • STOCK • 11/06/2026, 18:00:00
GRAL Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Grail, Inc. Class Action Lawsuit
GlobeNewsWire • STOCK • 11/06/2026, 15:58:00